Results 21 to 30 of about 647,233 (310)

Alzheimer’s disease and the fornix [PDF]

Frontiers in Aging Neuroscience, 2014
Alzheimer's disease (AD) is the most common form of neurodegenerative dementia. Researchers have long been focused on the cortical pathology of AD, since the most important pathologic features are the senile plaques found in the cortex, and the neurofibrillary tangles and neuronal loss that begin in the entorhinal cortex and the hippocampus.
Kenichi eOishi, Constantine eLyketsos, Constantine eLyketsos, Constantine eLyketsos   +3 more
openaire   +4 more sources

A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer's Disease Data. [PDF]

, 2019
There is well-documented evidence of brain network differences between individuals with Alzheimer's disease (AD) and healthy controls (HC). To date, imaging studies investigating brain networks in these populations have typically been cross-sectional ...
Alzheimer’s Disease Neuroimaging Initiative, Galvin, James, Guo, Ying, Kundu, Suprateek, Lukemire, Joshua, Wang, Yikai   +5 more
core   +2 more sources

Adipobiology of the brain: From brain diabetes to adipose Alzheimer‘s disease

Adipobiology, 2015
Accumulating evidence suggests that brain-adipose tissue bidirectional communications might be promising intervention point for cardiometabolic and neurodegenerative diseases (1). Alzheimer‘s disease (AD) is a progressive and yet incurable disorder characterized by memory loss and cognitive ability deterioration. It is the most common form of dementia,
Luigi Aloe, Anton B. Tonchev, Alexander Maucher, Marco Fiore, Marin D. Zhelezov, George N. Chaldakov   +5 more
openaire   +2 more sources

A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease

Alzheimer’s Research & Therapy, 2022
Background Cerebrospinal fluid (CSF) tau and beta-amyloid levels in chronic traumatic encephalopathy (CTE), a disease which can be clinically indistinguishable from Alzheimer’s disease (AD), are largely unknown.
Katherine W. Turk, Alexandra Geada, Victor E. Alvarez, Weiming Xia, Jonathan D. Cherry, Raymond Nicks, Gaoyuan Meng, Sarah Daley, Yorghos Tripodis, Bertrand R. Huber, Andrew E. Budson, Brigid Dwyer, Neil W. Kowall, Robert C. Cantu, Lee E. Goldstein, Douglas I. Katz, Robert A. Stern, Michael L. Alosco, Jesse Mez, Ann C. McKee, Thor D. Stein   +20 more
doaj   +1 more source

Understanding Alzheimer’s Disease Knowledge in Low-Income, Richmond, VA Community Dwelling Older Adults [PDF]

, 2020
Background: Different populations of individuals demonstrate varying levels of Alzheimer’s disease (AD) knowledge, as well as commonly held misconceptions about the nature of the disease and its risk factors.
Inker, Jennifer, Rhodes, Ann, Richardson, Joann, Wilkerson, Taylor, Zanjani, Faika   +4 more
core   +1 more source

Common age‐related neuropathologies and yearly variability in cognition

Annals of Clinical and Translational Neurology, 2019
Objective Cognitive variability is a potentially important source of heterogeneity in longitudinal cognitive profiles. We examined the extent to which common age‐related neuropathologies including Lewy bodies and Alzheimer’s disease (AD) contribute to ...
Lei Yu, Tianhao Wang, Robert S. Wilson, Sue Leurgans, Julie A. Schneider, David A. Bennett, Patricia A. Boyle   +6 more
doaj   +1 more source

Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology

Acta Neuropathologica Communications, 2022
Quantification of in vivo amyloid and tau PET imaging relationships with postmortem measurements are critical for validating the sensitivity and specificity imaging biomarkers across clinical phenotypes with Alzheimer disease neuropathologic change (ADNC)
Adam Martersteck, Ivan Ayala, Daniel T. Ohm, Callen Spencer, Christina Coventry, Sandra Weintraub, Eileen H. Bigio, M. -Marsel Mesulam, Changiz Geula, Emily Rogalski   +9 more
doaj   +1 more source

Low-Cost Portable Light Therapy for Alzheimer's Patients [PDF]

, 2019
This paper provides an overview of the information and research conducted that ushered the creation and innovation of a low-cost portable light therapy device to help treat Alzheimer’s patients.
Arasu, Melghi, Zoghi, Ben, Zoghi, Sara
core   +1 more source

CURCUMIN FOR ALZHEIMER’S DISEASE (AD) POTENTIAL TREATMENT

BIOMA, 2017
Various studies had been conducted regarding the effect of curcumin on AD patients, thus, many of the studies had suggested that curcumin had the potential to prevent and treat AD through several molecular mechanisms including act as anti-inflammatory, anti-oxidant, binding the Aβ plaques, metal chelation, and lowering cholesterol level.
Sutiono, Dias Rima, Iasmartua, Steven
openaire   +3 more sources

Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer’s Coordinating Center Uniform Data Set

Alzheimer’s Research & Therapy, 2019
Background Longitudinal investigations are needed to improve understanding of the contributions of cerebral small vessel disease to the clinical manifestation of Alzheimer’s disease, particularly in the early disease stages.
Christian Puzo, Caroline Labriola, Michael A. Sugarman, Yorghos Tripodis, Brett Martin, Joseph N. Palmisano, Eric G. Steinberg, Thor D. Stein, Neil W. Kowall, Ann C. McKee, Jesse Mez, Ronald J. Killiany, Robert A. Stern, Michael L. Alosco   +13 more
doaj   +1 more source